​

Funding Round

Series B - Vizgen

Series B - Vizgen

Investment Firm

Overview

Vizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.

Announced Date

Apr 07, 2021

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Novalis LifeSciences

Novalis LifeSciences

Novalis LifeSciences is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorNovalis LifeSciences
Participant InvestorPura Vida Investments
Participant InvestorTao Capital Partners
Participant InvestorDavid R. Walt
Participant InvestorARCH Venture Partners

Round Details and Background

Vizgen raised $37000000 on 2021-04-07 in Series B

Vizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 30, 2020
Series A - Vizgen
2-14.0M
Apr 07, 2021
Series B - Vizgen
6-37.0M
Jun 03, 2022
Series C - Vizgen
6-85.2M

Recent Activity

There is no recent news or activity for this profile.